A Non-interventional Pharmacovigilance Study of Osteonecrosis of the Jaw and Infection Leading to Hospitalization Among Patients With Cancer Treated With
XGEVA™ or Zoledronic Acid in Sweden, Denmark, and Norway (20101363)

11/02/2020
05/08/2020
EU PAS number:
EUPAS32437
Study
Finalised
Documents
Study protocol
Initial protocol
English (417.83 KB - PDF) View document
Study results
Study results
English (340.91 KB - PDF) View document
Study report
Other information